<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang C</submitter><funding>Peking University Medicine Sailing Program for Young Scholars’ Scientific &amp;amp; Technological Innovation</funding><funding>Peking University Medicine Sailing Program for Young Scholars' Scientific &amp; Technological Innovation</funding><funding>Natural Science Foundation of China</funding><funding>Beijing Nova Program</funding><funding>Technology special fund of Hainan Province</funding><pagination>123</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11087383</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>73(7)</volume><pubmed_abstract>Adoptively transferred T cell receptor-engineered T cells are a promising cancer treatment strategy, and the identification of tumour-specific TCRs is essential. Previous studies reported that tumour-reactive T cells and TCRs could be isolated based on the expression of activation markers. However, since T cells with different cell states could not respond uniformly to activation but show a heterogeneous expression profile of activation and effector molecules, isolation of tumour-reactive T cells based on single activation or effector molecules could result in the absence of tumour-reactive T cells; thus, combinations of multiple activation and effector molecules could improve the efficiency of isolating tumour-specific TCRs. We enrolled two patients with lung adenocarcinoma and obtained t</pubmed_abstract><journal>Cancer immunology, immunotherapy : CII</journal><pubmed_title>Single-cell sequencing of tumour infiltrating T cells efficiently identifies tumour-specific T cell receptors based on the T cell activation score.</pubmed_title><pmcid>PMC11087383</pmcid><funding_grant_id>20230484366</funding_grant_id><funding_grant_id>BMU2023YFJHPY011</funding_grant_id><funding_grant_id>ZDYF2024SHF2087</funding_grant_id><funding_grant_id>82373248</funding_grant_id><pubmed_authors>Shen L</pubmed_authors><pubmed_authors>Yang W</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Xiao Y</pubmed_authors><pubmed_authors>Lu Z</pubmed_authors><pubmed_authors>Teng X</pubmed_authors><pubmed_authors>Zhang C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Single-cell sequencing of tumour infiltrating T cells efficiently identifies tumour-specific T cell receptors based on the T cell activation score.</name><description>Adoptively transferred T cell receptor-engineered T cells are a promising cancer treatment strategy, and the identification of tumour-specific TCRs is essential. Previous studies reported that tumour-reactive T cells and TCRs could be isolated based on the expression of activation markers. However, since T cells with different cell states could not respond uniformly to activation but show a heterogeneous expression profile of activation and effector molecules, isolation of tumour-reactive T cells based on single activation or effector molecules could result in the absence of tumour-reactive T cells; thus, combinations of multiple activation and effector molecules could improve the efficiency of isolating tumour-specific TCRs. We enrolled two patients with lung adenocarcinoma and obtained t</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2026-04-16T03:19:33.669Z</modification><creation>2026-04-16T03:11:03.658Z</creation></dates><accession>S-EPMC11087383</accession><cross_references><pubmed>38727812</pubmed><doi>10.1007/s00262-024-03710-9</doi></cross_references></HashMap>